Metabolic dysfunction-associated steatohepatitis (MASH) is characterized by a complex interplay between gut microbiota-derived metabolites and hepatic immune infiltration. This study investigates the therapeutic mechanism of rifaximin, an oral non systemic antibiotic, in the context of MASH progress...
ORGANISM(S): Mus musculus
